Perrigo Co PLC (PRGO)
31.22
+0.74
(+2.41%)
USD |
NYSE |
Apr 24, 16:00
31.00
-0.22
(-0.72%)
After-Hours: 19:59
Perrigo SG&A Expense (Quarterly): 306.80M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 306.80M |
September 30, 2023 | 304.00M |
June 30, 2023 | 332.30M |
March 31, 2023 | 331.50M |
December 31, 2022 | 308.60M |
September 30, 2022 | 281.00M |
June 30, 2022 | 338.10M |
March 31, 2022 | 282.30M |
December 31, 2021 | 269.30M |
September 30, 2021 | 283.60M |
June 30, 2021 | 274.30M |
March 31, 2021 | 284.20M |
December 31, 2020 | 312.50M |
September 30, 2020 | 263.90M |
June 30, 2020 | 253.40M |
March 31, 2020 | 279.40M |
December 31, 2019 | 219.70M |
September 30, 2019 | 289.40M |
June 30, 2019 | 291.00M |
March 31, 2019 | 297.00M |
December 31, 2018 | 293.60M |
September 30, 2018 | 262.80M |
June 30, 2018 | 275.80M |
March 31, 2018 | 293.60M |
December 31, 2017 | 301.30M |
Date | Value |
---|---|
September 30, 2017 | 288.30M |
June 30, 2017 | 275.40M |
March 31, 2017 | 281.50M |
December 31, 2016 | 315.50M |
September 30, 2016 | 281.60M |
June 30, 2016 | 298.40M |
March 31, 2016 | 309.00M |
December 31, 2015 | 366.50M |
September 30, 2015 | 316.40M |
June 30, 2015 | 338.90M |
March 31, 2015 | 143.10M |
December 31, 2014 | 143.80M |
September 30, 2014 | 146.30M |
June 30, 2014 | 169.80M |
March 31, 2014 | 147.50M |
December 31, 2013 | 215.70M |
September 30, 2013 | 142.20M |
June 30, 2013 | 133.20M |
March 31, 2013 | 124.30M |
December 31, 2012 | 115.00M |
September 30, 2012 | 101.30M |
June 30, 2012 | 104.18M |
March 31, 2012 | 98.17M |
December 31, 2011 | 103.06M |
September 30, 2011 | 106.39M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
219.70M
Minimum
Dec 2019
338.10M
Maximum
Jun 2022
289.75M
Average
284.20M
Median
Mar 2021
SG&A Expense (Quarterly) Benchmarks
Alkermes PLC | 140.57M |
Endo International PLC | 140.43M |
Jazz Pharmaceuticals PLC | 396.03M |
Medtronic PLC | 2.673B |
Iterum Therapeutics PLC | 1.687M |